Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pizotifen Adjuvant to Escitalopram in Depression
NCT06500624Completed
- Sponsor
- Riphah International University
- Start
- Jun 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pizotifen in major depressive disorder (MDD) (2 arms), sponsored by Riphah International University. Primary endpoint: Patient Health Questionnaire-9 at 4 weeks. Started Jun 2024; status: completed.
02
Drugs
pizotifen
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06500624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06500624.